In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: A T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model

European Journal of Neuroscience

Volumn 33, Issue 8, 2011, Pages 1551-1560

  Soria, Guadalupe ^a,b   Aguilar, Esther ^b   Tudela, Raúl ^b,c   Mullol, Joaquim ^b   Planas, Anna M ^a,b   Marin, Concepció ^b,d  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Axonal transport; Diffusion tensor imaging; in vivo magnetic resonance imaging; Manganese enhanced magnetic resonance imaging; Parkinson's disease

Indexed keywords

DOPAMINE TRANSPORTER; MANGANESE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LONGITUDINAL STUDY; MALE; NERVE CELL DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RAT; RELAXATION TIME; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; CHLORIDES; DIFFUSION TENSOR IMAGING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE COMPOUNDS; OXIDOPAMINE; PARKINSON DISEASE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79954565846     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07639.x     Document Type: Article

References (49)

1. Albin, R.L., Young, A.B. & Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366-375.
2. Arfanakis, K., Haughton, V.M., Carew, J.D., Rogers, B.P., Dempsey, R.J. & Meyerand, M.E. (2002) Diffusion tensor MR imaging in diffuse axonal injury. AJNR Am. J. Neuroradiol., 23, 794-802.
3. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. & Seitelberger, F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci., 20, 415-455.
4. Blandini, F., Levandis, G., Bazzini, E., Nappi, G. & Armentero, M.T. (2007) Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from and old model. Eur. J. Neurosci., 25, 397-405.
5. Boska, M.D., Hasan, K.M., Kibuule, D., Banerjee, R., McIntyre, E., Nelson, J.A., Hahn, T., Gendelman, H.E. & Mosley, R.L. (2007) Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Neurobiol. Dis., 26, 590-596.
6. Breit, S., Martin, A., Lessmann, L., Cerkez, D., Gasser, T. & Schulz, J.B. (2008) Bilateral changes in neuronal activity of the basal ganglia in the unilateral 6-hydroxydopamine rat model. J. Neurosci. Res., 86, 1388-1396.
7. Budde, M.D., Kim, J.H., Liang, H.F., Schmidt, R.E., Russell, J.H., Cross, A.H. & Song, S.K. (2007) Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn. Reson. Med., 57, 688-695.
8. Chan, L.L., Rumpel, H., Yap, K., Lee, E., Loo, H.V., Ho, G.L., Fook-Chong, S., Yuen, Y. & Tan, E.K. (2007) Case control study of diffusion tensor imaging in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 78, 1383-1386.
9. Clarke, N.P., Bolam, J.P. & Bevan, M.D. (1996) Glutamate-enriched inputs from the mesopontine tegmentum to the entopeduncular nucleus in the rat. Eur. J. Neurosci., 8, 1363-1376.
10. De Long, M.R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci., 13, 281-285.
11. Dijkhuizen, R.M. & Nicolay, K. (2003) Magnetic resonance imaging in experimental models of brain disorders. J. Cereb. Blood Flow Metab., 23, 1383-1402.
12. Gerfen, C.R., Staines, W.A., Arbuthnott, G.W. & Fibiger, H.C. (1982) Crossed connections of the substantia nigra in the rat. J. Comp. Neurol., 207, 283-303.
13. Hasan, K.M. & Narayana, P.A. (2006) Retrospective measurement of the diffusion tensor eigenvalues from diffusion anisotropy and mean diffusivity in DTI. Magn. Reson. Med., 56, 130-137.
14. Hazrati, L.N. & Parent, A. (1991) Contralateral pallidothalamic and pallidotegmental projections in primates: an anterograde and retrograde labeling study. Brain Res., 567, 212-223.
15. Henning, J., Strauss, U., Wree, A., Gimsa, J., Rolfs, A., Benecke, R. & Gimsa, U. (2008) Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease. Neurosci. Res., 62, 246-253.
16. Jellinger, K.A. (2002) Recent developments in the pathology of Parkinson's disease. J. Neural Transm. Suppl., 62, 347-376.
17. Karagulle Kendi, A.T., Lehericy, S., Luciana, M., Ugurbil, K. & Tuite, P. (2008) Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am. J. Neuroradiol., 29, 501-505.
18. Kondoh, T., Bannai, M., Nishino, H. & Torii, K. (2005) 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging. Exp. Neurol., 192, 194-202.
19. Lane, E. & Dunnett, S. (2008) Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic? Psychopharmacology (Berl), 199, 303-312.
20. Lang, A.E. & Lozano, A.M. (1998) Parkinson's disease. First of two parts. N. Engl. J. Med., 339, 1044-1053.
21. Larsson, H.B., Frederiksen, J., Petersen, J., Nordenbo, A., Zeeberg, I., Henriksen, O. & Olesen, J. (1989) Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn. Reson. Med., 11, 337-348.
22. Lavoie, B. & Parent, A. (1994) Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J. Comp Neurol., 344, 210-231.
23. Lazar, M., Lee, J.H. & Alexander, A.L. (2005) Axial asymmetry of water diffusion in brain white matter. Magn. Reson. Med., 54, 860-867.
24. Mamere, A.E., Saraiva, L.A., Matos, A.L., Carneiro, A.A. & Santos, A.C. (2009) Evaluation of delayed neuronal and axonal damage secondary to moderate and severe traumatic brain injury using quantitative MR imaging techniques. AJNR Am. J. Neuroradiol., 30, 947-952.
25. Marin, C., Aguilar, E., Mengod, G., Cortés, R., Rodríguez-Oroz, M.C. & Obeso, J.A. (2008) Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes. Neurobiol. Dis., 32, 340-348.
26. Marin, C., Aguilar, E., Mengod, G., Cortés, R. & Obeso, J.A. (2009) Effects of early vs late initiation of levodopa treatment in hemiparkinsonian rats. Eur. J. Neurosci., 30, 823-832.
27. Miklyaeva, E.I., Whishaw, I.Q. & Kolb, B. (2007) A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere. Restor. Neurol. Neurosci., 25, 91-99.
28. Morfini, G., Pigino, G., Opalach, K., Serulle, Y., Moreira, J.E., Sugimori, M., Llinas, R.R. & Brady, S.T. (2007) 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc. Natl Acad. Sci. USA, 104, 2442-2447.
29. Morfini, G.A., Burns, M., Binder, L.I., Kanaan, N.M., La Pointe, N., Bosco, D.A., Brown, R.H. Jr, Brown, H., Tiwari, A., Hayward, L., Edgar, J., Nave, K.A., Garberrn, J., Atagi, Y., Song, Y., Pigino, G. & Brady, S.T. (2009) Axonal transport defects in neurodegenerative diseases. J. Neurosci., 29, 12776-12786.
30. Mouroux, M., Hassani, O.K. & Feger, J. (1995) Electrophysiological study of the excitatory parafascicular projection to the subthalamic nucleus and evidence for ipsi- and contralateral controls. Neuroscience, 67, 399-407.
31. Obeso, J.A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temino, B., Mena-Segovia, J., Rodriguez, M. & Olanow, C.W. (2008) The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann. Neurol., 64(Suppl 2), S30-S46.
32. Papa, S.M., Engber, T.M., Kask, A.M. & Chase, T.N. (1994) Motor fluctuations in levodopa-treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res., 662, 69-74.
33. Pautler, R.G. & Koretsky, A.P. (2002) Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage, 16, 441-448.
34. Pautler, R.G., Silva, A.C. & Koretsky, A.P. (1998) In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med., 40, 740-748.
35. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
36. Pelled, G., Bergman, H. & Goelman, G. (2002) Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study. Eur. J. Neurosci., 15, 389-394.
37. Pelled, G., Bergman, H., Ben Hur, T. & Goelman, G. (2005) Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study. Eur. J. Neurosci., 21, 2227-2232.
38. Pelled, G., Bergman, H., Ben Hur, T. & Goelman, G. (2007) Manganese-enhanced MRI in a rat model of Parkinson's disease. J. Magn. Reson. Imaging, 26, 863-870.
39. Pellegrino, D., Cicchetti, F., Wang, X., Zhu, A., Yu, M., Saint-Pierre, M. & Brownell, A.L. (2007) Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J. Nucl. Med., 48, 1147-1153.
40. Persigehl, T., Heindel, W. & Bremer, C. (2005) MR and optical approaches to molecular imaging. Abdom. Imaging, 30, 342-354.
41. Pierucci, M., Di Matteo, V., Benigno, A., Crescimanno, G., Esposito, E. & Di Giovanni, G. (2009) The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry. Ann. NY Acad. Sci., 1155, 316-323.
42. Stevenson, A., Yates, D.M., Manser, C., De Vos, K.J., Vagnoni, A., Leigh, P.N., Mc Loughlin, D.M. & Miller, C.C. (2009) Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neurosci. Lett., 454, 161-164.
43. Tievsky, A.L., Ptak, T. & Farkas, J. (1999) Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am. J. Neuroradiol., 20, 1491-1499.
44. Vaillancourt, D.E., Spraker, M.B., Prodoehl, J., Abraham, I., Corcos, D.M., Zhou, X.J., Comella, C.L. & Little, D.M. (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology, 72, 1378-1384.
45. Van Camp, N., Blockx, I., Verhoye, M., Casteels, C., Coun, F., Leemans, A., Sijbers, J., Baekelandt, V., Van Laere, K. & Van der Linden, A. (2009) Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract. NMR Biomed., 22, 697-706.
46. Van der Linden, A., Van Meir, V., Tindemans, I., Verhoye, M. & Balthazart, J. (2004) Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to image brain plasticity in song birds. NMR Biomed., 17, 602-612.
47. Van Meir, V. & Van der Linden, A. (2007). Functional cellular imaging with manganese. In Modo, M.M.J. & Bulte, J.W.M. (Eds), Molecular Cell MR Imaging. CRC Press, Florida, USA, pp. 369-392.
48. Wegener, S., Weber, R., Ramos-Cabrer, P., Uhlenkueken, U., Sprenger, C., Wiedermann, D., Villringer, A. & Hoehn, M. (2006) Temporal profile of T2-weighted MRI distinguishes between pannecrosis and selective neuronal death after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab., 26, 38-47.
49. Zhang, K., Yu, C., Zhang, Y., Wu, X., Zhu, C., Chan, P. & Li, K. (2011) Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. Eur. J. Radiol., 77, 269-273.